Correction to “Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges”

Shu-Jin Li , Jia-Xian Chen , Zhijun Sun

Cancer Communications ›› 2025, Vol. 45 ›› Issue (10) : 1339 -1340.

PDF
Cancer Communications ›› 2025, Vol. 45 ›› Issue (10) : 1339 -1340. DOI: 10.1002/cac2.70060
CORRECTION

Correction to “Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges”

Author information +
History +
PDF

Cite this article

Download citation ▾
Shu-Jin Li, Jia-Xian Chen, Zhijun Sun. Correction to “Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges”. Cancer Communications, 2025, 45(10): 1339-1340 DOI:10.1002/cac2.70060

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2025 The Author(s). Cancer Communications published by John Wiley & Sons Australia, Ltd on behalf of Sun Yat-sen University Cancer Center.

AI Summary AI Mindmap
PDF

51

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/